Aligning Preclinical InVivo Models of Parkinson’s Disease (PD) with Biological Classifications of PD
- Examine why models differ in their degree of predictive validity for symptomatic and disease modifying therapies
- Where do current models of PD sit within biological classifications of PD?
- What should next generation models of PD focus on?